— Know what they know.
Not Investment Advice

EOG vs OXY vs FANG

161 measures in 16 categories, one definition each, computed from filings and market data.
EOG83.3
EOG Resources, Inc.
Energy · Oil & Gas Exploration & Production
$158.01 +4.23%$82.9B mkt cap
Score DNA
OXY68.5
Occidental Petroleum Corporation
Energy · Oil & Gas Exploration & Production
$62.38 +2.84%$62.4B mkt cap
Score DNA
FANG49.7
Diamondback Energy, Inc.
Energy · Oil & Gas Exploration & Production
$203.95 +4.27%$57.1B mkt cap
Score DNA

Price, rebased to 100 three years ago

EOG   OXY   FANG   · weekly adjusted closes
6080100120140Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26FANG 134EOG 132OXY 101
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureEOGOXYFANG
Insider open-market buys, 180d 0 1 0
Insider $ bought, 180d — $0.25M —
Congress purchases, 180d 0 0 0
Last Congress purchase — — —
13F net change in holders +26 −61 −2
ETFs adding shares, 30d 1,147 929 1,178
ETFs trimming, 30d 882 604 735
Net ETF funds, 30d +265 +325 +443

Valuation

16 measures
MeasureEOGOXYFANG
P/E (TTM) 12.1x
62nd
8.6x
24th
36.0x
91st
PEG (P/E ÷ 3-yr EPS CAGR) — 15.89 —
Price / sales 3.1x
79th
2.5x
66th
3.3x
81st
Price / book 2.6x
85th
1.5x
52nd
1.5x
57th
Price / tangible book 2.2x
85th
1.2x
43rd
1.3x
48th
Price / free cash flow 12.3x
68th
11.7x
59th
8.8x
35th
Price / operating cash flow 6.2x
78th
5.7x
70th
5.6x
65th
Enterprise value $86.2B
98th
$72.8B
96th
$69.3B
94th
EV / sales 3.2x
70th
2.9x
60th
4.0x
81st
EV / EBITDA 6.1x
52nd
5.2x
34th
9.7x
75th
EV / EBIT 9.6x
42nd
11.5x
67th
37.1x
94th
EV / free cash flow 12.8x
51st
13.7x
57th
10.7x
43rd
Earnings yield 8.3%
55th
11.6%
83rd
2.8%
34th
FCF yield 8.1%
47th
8.5%
53rd
11.4%
72nd
Operating cash flow yield 16.1%
23rd
17.6%
32nd
17.8%
36th
Graham number (per share) $132.73
88th
$81.55
79th
$130.78
85th

Profitability (TTM)

12 measures
MeasureEOGOXYFANG
Gross margin 75.7%
89th
43.4%
40th
44.5%
43rd
EBITDA margin 52.9%
57th
55.5%
62nd
41.7%
36th
Operating margin 39.1%
81st
23.0%
45th
27.7%
60th
EBIT margin 33.7%
68th
25.1%
49th
10.9%
36th
Net margin 25.7%
77th
28.8%
85th
9.3%
30th
NOPAT margin 30.7%
72nd
16.9%
43rd
22.7%
57th
FCF margin 25.1%
68th
21.1%
53rd
38.0%
81st
Operating cash flow margin 49.9%
64th
43.6%
34th
59.3%
77th
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 20.1%
94th
4.1%
32nd
1.7%
4th
Stock comp / revenue 0.9%
49th
0.0%
0th
0.1%
19th
Effective tax rate 21.6%
72nd
26.6%
89th
18.0%
26th

Returns on capital

11 measures
MeasureEOGOXYFANG
ROE (on average equity) 22.5%
83rd
18.7%
70th
4.1%
28th
ROA 13.6%
89th
8.8%
68th
2.2%
30th
ROIC 23.3%
87th
8.1%
40th
7.8%
38th
ROCE 18.2%
85th
8.7%
43rd
2.9%
32nd
Return on tangible assets 17.9%
85th
7.7%
40th
2.6%
32nd
Cash ROIC (OCF / invested capital) 37.9%
85th
21.0%
43rd
20.3%
38th
Gross profitability (GP / assets) 36.9%
96th
13.6%
34th
10.8%
17th
ROIC, 3-yr average 19.6%
91st
5.5%
30th
8.5%
50th
ROIC, 5-yr average 25.2%
82nd
9.7%
31st
12.7%
38th
ROE, 5-yr average 25.1%
72nd
20.2%
46th
17.0%
38th
Incremental ROIC 58.9%
70th
-71.4%
15th
-21.0%
20th

Growth

17 measures
MeasureEOGOXYFANG
Revenue growth (TTM YoY) 17.8%
59th
-7.5%
11th
22.0%
70th
Revenue growth (QoQ) 27.6%
55th
59.2%
89th
31.2%
62nd
Revenue CAGR, 3 yr 2.1%
50th
-7.1%
14th
27.2%
88th
Revenue CAGR, 5 yr 14.3%
33rd
4.9%
3rd
31.5%
77th
Gross profit CAGR, 3 yr 1.8%
62nd
-4.6%
43rd
13.6%
79th
Operating income CAGR, 3 yr -1.9%
73rd
-14.2%
51st
-1.1%
76th
Net income growth (TTM YoY) 20.0%
45th
206.7%
87th
-58.7%
0th
Net income CAGR, 3 yr -7.6%
72nd
2.4%
86th
-22.9%
24th
EPS growth (TTM YoY) 23.8%
52nd
206.2%
87th
-57.1%
0th
EPS CAGR, 3 yr -4.5%
86th
0.5%
93rd
-33.5%
10th
EPS CAGR, 5 yr 32.2%
62nd
— —
FCF growth (TTM YoY) 48.5%
63rd
10.7%
33rd
—
FCF CAGR, 3 yr -5.8%
30th
-14.9%
20th
56.8%
97th
Operating cash flow CAGR, 3 yr -1.0%
38th
-8.2%
19th
17.2%
81st
Book value CAGR, 3 yr 10.2%
56th
10.7%
63rd
16.1%
83rd
Dividend CAGR, 3 yr 4.5%
88th
0.9%
75th
-9.4%
34th
Sustainable growth rate 15.4%
74th
14.5%
68th
0.3%
15th

Margin history & stability

7 measures
MeasureEOGOXYFANG
Gross margin, 3-yr average 73.9%
91st
37.8%
32nd
46.5%
50th
Operating margin, 3-yr average 36.9%
77th
21.9%
34th
38.3%
82nd
Net margin, 3-yr average 27.4%
82nd
18.0%
55th
24.8%
75th
FCF margin, 3-yr average 22.0%
75th
17.9%
55th
0.1%
18th
Revenue stability (0-1) 0.68
48th
0.16
20th
0.95
82nd
Earnings stability (0-1) 0.30
73rd
0.10
43rd
0.14
50th
Margin stability (0-1) 0.93
93rd
0.67
20th
0.83
64th

Liquidity (latest quarter)

7 measures
MeasureEOGOXYFANG
Cash & short-term investments $4.9B
98th
$4.2B
94th
$462.0M
74th
Net cash (− = net debt) −$3.3B
23rd
−$10.5B
6th
−$12.2B
2nd
Working capital $4.5B
98th
$3.2B
96th
−$3.0B
0th
Current ratio 1.85
87th
1.41
79th
0.47
9th
Quick ratio 1.68
87th
1.13
68th
0.45
13th
Cash ratio (cash + ST investments / current liabilities) 0.92
87th
0.53
70th
0.08
28th
Defensive interval (days) 315 days
43rd
584 days
68th
304 days
34th

Leverage & solvency (latest quarter)

13 measures
MeasureEOGOXYFANG
Total debt $8.2B
89th
$14.6B
98th
$12.6B
94th
Debt / equity 0.26
24th
0.35
35th
0.33
33rd
Net debt / equity 0.10
13th
0.25
30th
0.32
39th
Debt / assets 15.1%
23rd
18.2%
34th
18.0%
32nd
Debt / capital 20.6%
24th
25.9%
35th
25.0%
33rd
Debt / EBITDA 0.58
14th
1.05
36th
1.77
52nd
Net debt / EBITDA 0.24
11th
0.75
30th
1.71
59th
Interest coverage (EBIT / interest) 35.4x
93rd
7.5x
62nd
7.0x
60th
Cash interest coverage 52.4x
91st
13.0x
54th
38.0x
87th
Debt payback (years of OCF) 0.6 yrs
17th
1.3 yrs
48th
1.2 yrs
43rd
Liabilities / assets 41.8%
40th
47.3%
51st
37.4%
21st
IS credit model rating AA+ A A-
Implied credit spread (bps) 65
11th
150
32nd
175
38th

Efficiency

11 measures
MeasureEOGOXYFANG
Asset turnover 0.53
87th
0.31
26th
0.24
9th
Fixed asset turnover 0.62
67th
0.19
2nd
0.26
7th
Inventory turnover 7.0
10th
7.0
14th
104.4
90th
Receivables turnover 8.9
47th
7.6
30th
10.7
62nd
Days sales outstanding 41 days
53rd
48 days
70th
34 days
38th
Days inventory outstanding 52 days
90th
52 days
86th
3 days
10th
Days payables outstanding 158 days
87th
95 days
70th
28 days
21st
Cash conversion cycle (days) −65 days
26th
5 days
60th
9 days
66th
Capex / revenue 24.8%
50th
22.5%
39th
21.3%
35th
Capex / depreciation 1.29
63rd
0.74
35th
0.69
28th
Operating expense ratio 39.7%
72nd
35.6%
68th
0.0%
0th

Cash flow & earnings quality

7 measures
MeasureEOGOXYFANG
Operating cash flow / net income 1.94
35th
1.51
18th
6.40
97th
FCF / net income 0.98
50th
0.73
32nd
4.10
94th
FCF / operating cash flow 50.4%
66th
48.4%
59th
64.1%
77th
Capex / operating cash flow 49.6%
36th
51.6%
42nd
35.9%
24th
Accruals ratio -12.8%
45th
-4.5%
87th
-12.0%
51st
Sloan accruals ratio -9.2%
55th
-5.9%
81st
-9.3%
53rd
Earnings quality score (0-1) 0.75
0th
1.00
82nd
0.75
0th

Dividends & buybacks

9 measures
MeasureEOGOXYFANG
Dividend yield 2.6%
57th
1.7%
38th
2.1%
45th
Dividend per share (TTM) $4.08
96th
$1.04
55th
$4.25
98th
Payout ratio (dividends / net income) 31.7%
64th
22.8%
36th
92.0%
85th
Dividends / FCF 32.4%
72nd
31.2%
69th
22.5%
56th
Dividend growth (YoY) 6.7%
75th
8.3%
78th
20.4%
89th
Buyback yield 3.5%
87th
0.2%
47th
3.4%
83rd
Shareholder yield (dividends + buybacks) 6.1%
70th
2.8%
34th
6.0%
68th
Share count change (YoY) -3.1%
17th
0.2%
45th
-3.7%
11th
Buybacks, last 5 years $13.7B
98th
$209.0M
55th
$1.2B
83rd

Scores & forensic checks

15 measures
MeasureEOGOXYFANG
IS score 83
96th
68
66th
50
38th
IS profitability 92
94th
84
81st
59
26th
IS growth 69
63rd
51
39th
38
20th
IS value 76
60th
87
87th
59
36th
IS momentum 93
63rd
80
46th
68
33rd
IS risk (safety) 90
89th
50
62nd
30
34th
IS quality 93
94th
88
81st
81
51st
IS balance sheet 82
91st
71
77th
59
55th
IS earnings quality 61
51st
75
85th
65
60th
IS cash flow 81
74th
66
55th
76
70th
Piotroski F-score (0-9) 8
79th
7
43rd
7
43rd
Altman Z-score 3.8
89th
1.9
64th
1.5
45th
Beneish M-score −2.72
51st
−8.07
2nd
−2.72
49th
Ohlson O-score −10.35
15th
−9.70
28th
−9.55
30th
IS credit score 94
89th
73
68th
69
62nd

Per share

7 measures
MeasureEOGOXYFANG
EPS, diluted (TTM) $13.00
96th
$7.17
83rd
$5.64
74th
Book value per share $60.23
89th
$41.24
81st
$134.78
98th
Tangible book per share $60.58
89th
$42.50
79th
$156.42
100th
Revenue per share $50.56
87th
$24.89
72nd
$60.82
94th
FCF per share $12.71
87th
$5.25
70th
$23.10
100th
Operating cash flow per share $25.25
91st
$10.84
70th
$36.07
94th
Cash per share $9.28
96th
$4.10
83rd
$1.64
60th

Size (TTM)

8 measures
MeasureEOGOXYFANG
Market cap $82.9B
98th
$62.4B
96th
$57.1B
94th
Revenue $26.7B
96th
$25.2B
94th
$17.1B
89th
EBITDA $14.1B
96th
$14.0B
94th
$7.1B
89th
Net income $6.9B
96th
$7.3B
98th
$1.6B
83rd
Free cash flow $6.7B
98th
$5.3B
94th
$6.5B
96th
Total assets $54.8B
89th
$80.4B
98th
$70.2B
94th
Shareholders' equity $31.9B
89th
$41.7B
96th
$37.9B
94th
Employees 3,400
94th
10,412
100th
1,762
83rd

Price performance

9 measures
MeasureEOGOXYFANG
1 day +4.2% +2.8% +4.3%
1 week +7.4% +3.8% +6.2%
1 month +9.3% +5.2% +3.6%
3 months +12.7% +13.1% +4.4%
6 months +24.8% +16.0% +13.1%
Year to date +52.0% +47.2% +33.9%
1 year +51.5% +49.8% +44.7%
3 years, cumulative +38.9% +2.6% +40.9%
5 years, cumulative +122.5% +96.7% +125.5%

Technicals

4 measures
MeasureEOGOXYFANG
RSI 14 71.3 63.7 64.4
From 52-week high −0.2% −7.5% −6.0%
From 52-week low +60.5% +60.8% +49.9%
Beta 0.27 0.16 0.41
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms